CoChat

Tumor Necrosis Factor Receptor 1 Gain-of-Function Mutation Aggravates Nonalcoholic Fatty Liver Disease but Does Not Cause Insulin Resistance in a Murine Model

Open access
Aparicio-Vergara, Marcela, Hommelberg, Pascal P.H., Schreurs, Marijke, Gruben, Nanda, Stienstra, Rinke, Shiri-Sverdlov, Ronit, Kloosterhuis, Niels J., de Bruin, Alain, van de Sluis, Bart, Koonen, Debby P.Y., Hofker, Marten H. · 2013 · Hepatology
Cited by 40

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Ectodomain shedding of tumor necrosis factor receptor 1 (TNFR1) provides negative feedback to the inflammatory loop induced by TNFα. As the significance of this mechanism in obesity-associated pathologies is unclear, we aimed to unravel how much TNFR1 ectodomain shedding controls the development of nonalcoholic fatty liver disease (NAFLD), as well as its role in the development of insulin resistance. We used knockin mice expressing a mutated TNFR1 ectodomain (p55Δns), incapable of shedding and dampen the inflammatory response. Our data show that persistent TNFα signaling through this inability of TNFR1 ectodomain shedding contributes to chronic low-grade inflammation, which is confined to the liver. In spite of this, hepatic lipid levels were not affected by the nonshedding mutation in mice fed a chow diet, nor were they worse off following 12 weeks of high-fat diet (HFD) than controls (p55+/+) fed an HFD. We detected inflammatory infiltrates, hepatocellular necrosis, and apoptosis in livers of p55Δns/Δns mice fed an HFD, suggesting advanced progression of NAFLD toward nonalcoholic steatohepatitis (NASH). Indeed, fibrosis was present in p55Δns/Δns mice, but absent in wildtype mice, confirming that the p55Δns/Δns mice had a more severe NASH phenotype. Despite low-grade hepatic inflammation, insulin resistance was not observed in p55Δns/Δns mice fed a chow diet, and HFD-induced insulin resistance was no worse in p55Δns/Δns mice than p55+/+ mice. Conclusion: TNFR1 ectodomain shedding is not an essential feedback mechanism in preventing the development of hepatic steatosis or insulin resistance. It is, however, pivotal in attenuating the progression from “simple steatosis” towards a more serious phenotype with many NASH features. Targeting TNFR1 could therefore be beneficial in attenuating NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.26046

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 36

  1. Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome., HEPATOLOGY, 37, 917923, 10.1053/jhep.2003.50161 · DOI · Paper page
  2. Anderson, 2008, Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis., Pharmacol Rev, 60, 311357, 10.1124/pr.108.00001 · DOI · Paper page
  3. Tilg, 2000, Cytokines in alcoholic and nonalcoholic steatohepatitis., N Engl J Med, 343, 14671476, 10.1056/NEJM200011163432007 · DOI · Paper page
  4. Abiru, 2006, Serum cytokine and soluble cytokine receptor levels in patients with nonalcoholic steatohepatitis., Liver Int, 26, 3945, 10.1111/j.1478-3231.2005.01191.x · DOI · Paper page
  5. Crespo, 2001, Gene expression of tumor necrosis factor alpha and TNFreceptors, p55 and p75, in nonalcoholic steatohepatitis patients., HEPATOLOGY, 34, 11581163, 10.1053/jhep.2001.29628 · DOI · Paper page
  6. Endo, 2007, TNFalpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein1c (SREBP1c)., Exp Biol Med (Maywood), 232, 614621
  7. Li, 2003, Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease., HEPATOLOGY, 37, 343350, 10.1053/jhep.2003.50048 · DOI · Paper page
  8. Memon, 2001, TNFalpha is not the cause of fatty liver disease in obese diabetic mice., Nat Med, 7, 23, 10.1038/83316 · DOI
  9. Dela, 2005, NFkappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis., Gastroenterology, 129, 16631674
  10. SchnyderCandrian, 2005, Hepatic steatosis in the absence of tumor necrosis factor in mice., Cytokine, 32, 287295, 10.1016/j.cyto.2005.11.004 · DOI
  11. Toda, 2010, Deletion of tumor necrosis factoralpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in aromatase knockout mice., Biochim Biophys Acta, 1801, 655664
  12. Tomita, 2006, Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of nonalcoholic steatohepatitis in mice., Gut, 55, 415424, 10.1136/gut.2005.071118 · DOI · Paper page
  13. Uysal, 1997, Protection from obesityinduced insulin resistance in mice lacking TNFalpha function., Nature, 389, 610614, 10.1038/39335 · DOI · Paper page
  14. Pamir, 2009, Receptors for tumor necrosis factoralpha play a protective role against obesity and alter adipose tissue macrophage status., Endocrinology, 150, 41244134, 10.1210/en.2009-0137 · DOI · Paper page
  15. Romanatto, 2009, Deletion of tumor necrosis factoralpha receptor 1 (TNFR1) protects against dietinduced obesity by means of increased thermogenesis., J Biol Chem, 284, 3621336222, 10.1074/jbc.M109.030874 · DOI · Paper page
  16. Schreyer, 1998, Obesity and diabetes in TNFalpha receptordeficient mice., J Clin Invest, 102, 402411, 10.1172/JCI2849 · DOI · Paper page
  17. Hotamisligil, 1993, Adipose expression of tumor necrosis factoralpha: direct role in obesitylinked insulin resistance., Science, 259, 8791, 10.1126/science.7678183 · DOI · Paper page
  18. Ofei, 1996, Effects of an engineered human antiTNFalpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM., Diabetes, 45, 881885, 10.2337/diab.45.7.881 · DOI · Paper page
  19. Van Zee, 1992, Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo., Proc Natl Acad Sci U S A, 89, 48454849, 10.1073/pnas.89.11.4845 · DOI · Paper page
  20. Rowlands, 2011, Activation of TNFR1 ectodomain shedding by mitochondrial Ca2 determines the severity of inflammation in mouse lung microvessels., J Clin Invest, 121, 19861999, 10.1172/JCI43839 · DOI · Paper page
  21. Monroy, 2009, Impaired regulation of the TNFalpha converting enzymetissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans., Diabetologia, 52, 21692181, 10.1007/s00125-009-1451-3 · DOI
  22. Fiorentino, 2010, Increased tumor necrosis factor alphaconverting enzyme activity induces insulin resistance and hepatosteatosis in mice., HEPATOLOGY, 51, 103110, 10.1002/hep.23250 · DOI
  23. de Meijer, 2011, Tumor necrosis factor alphaconverting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in mice., PLoS ONE, 6, e25587, 10.1371/journal.pone.0025587 · DOI
  24. Serino, 2007, Mice heterozygous for tumor necrosis factoralpha converting enzyme are protected from obesityinduced insulin resistance and diabetes., Diabetes, 56, 25412546, 10.2337/db07-0360 · DOI · Paper page
  25. Seals, 2003, The ADAMs family of metalloproteases: multidomain proteins with multiple functions., Genes Dev, 17, 730, 10.1101/gad.1039703 · DOI · Paper page
  26. Xanthoulea, 2004, Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases., J Exp Med, 200, 367376, 10.1084/jem.20040435 · DOI · Paper page
  27. Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease., HEPATOLOGY, 41, 13131321, 10.1002/hep.20701 · DOI · Paper page
  28. Chen, 2009, TNFalpha, a potent lipid metabolism regulator., Cell Biochem Funct, 27, 407416, 10.1002/cbf.1596 · DOI · Paper page
  29. Feingold, 1987, Tumor necrosis factoralpha stimulates hepatic lipogenesis in the rat in vivo., J Clin Invest, 80, 184190, 10.1172/JCI113046 · DOI · Paper page
  30. Comhair, 2011, Dietary cholesterol, female gender and n3 fatty acid deficiency are more important factors in the development of nonalcoholic fatty liver disease than the saturation index of the fat., Nutr Metab (Lond), 8, 4, 10.1186/1743-7075-8-4 · DOI
  31. Wouters, 2008, Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis., HEPATOLOGY, 48, 474486, 10.1002/hep.22363 · DOI · Paper page
  32. Tilg, 2008, Insulin resistance, inflammation, and nonalcoholic fatty liver disease., Trends Endocrinol Metab, 19, 371379, 10.1016/j.tem.2008.08.005 · DOI · Paper page
  33. Fon, 2007, TNFalpha interferes with lipid homeostasis and activates acute and proatherogenic processes., Physiol Genomics, 31, 216227
  34. Fracanzani, 2008, Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes., HEPATOLOGY, 48, 792798
  35. Bieghs, 2012, LDL Receptor knockout mice are a physiological model particularly vulnerable to study the onset of Inflammation in nonalcoholic fatty liver disease., PLoS ONE, 7, e30668, 10.1371/journal.pone.0030668 · DOI · Paper page
  36. Kaneko, 2011, Tumor necrosis factoralpha converting enzyme inactivation ameliorates highfat dietinduced insulin resistance and altered energy homeostasis., Circ J, 75, 24822490, 10.1253/circj.CJ-11-0182 · DOI

Cited by

See all 40

Metadata

Authors
Aparicio-Vergara, M., Hommelberg, P. P. H., Schreurs, M., Gruben, N., Stienstra, R., Shiri-Sverdlov, R., Kloosterhuis, N. J., de Bruin, A., van de Sluis, B., Koonen, D. P. Y., & Hofker, M. H.
Venue
Hepatology
Published
2013-02
Volume
57
Issue
2
Pages
566-576
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2134626804
Cited by
40
References
5
FWCI
3.23
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 942 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor Necrosis Factor Receptor 1 Gain-of-Function Mutation Aggravates Nonalcoholic Fatty Liver Disease but Does Not Cause Insulin Resistance in a Murine Model. https://app.cochat.ai/papers/10.1002/hep.26046
The paper
Aparicio-Vergara, M., Hommelberg, P. P. H., Schreurs, M., Gruben, N., Stienstra, R., Shiri-Sverdlov, R., Kloosterhuis, N. J., de Bruin, A., van de Sluis, B., Koonen, D. P. Y., & Hofker, M. H. (2013). Tumor Necrosis Factor Receptor 1 Gain-of-Function Mutation Aggravates Nonalcoholic Fatty Liver Disease but Does Not Cause Insulin Resistance in a Murine Model. Hepatology. https://doi.org/10.1002/hep.26046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.